NCT03298438

Study About Annoucement of the Diagnosis of Neurofibromatosis 1 in de Novo Forms

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 31 (actual)
• Sponsor: University Hospital, Brest · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominant genetic disorders. The aim of our study was to evaluate post-traumatic stress disorder (PTSD) in patients and their families following the disclosure of sporadic NF1. Diagnosis of NF1 was retained according to NIH criteria, familial forms were excluded. The French version of the Impact of Event Scale-Revised was used for the diagnosis of PTSD.

Conditions

• Neurofibromatosis 1
• Diagnoses Disease
• Post Traumatic Stress Disorder

Timeline

• Start date: 2016-07-15
• Primary completion: 2016-12-31
• Completion: 2016-12-31
• First posted: 2017-10-02
• Last updated: 2017-10-02

Locations

1 site across 1 country: France